Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.93
+0.10001.46%
Post-market: 6.90-0.0300-0.43%19:50 EDT
Volume:6.04M
Turnover:42.23M
Market Cap:2.43B
PE:-15.80
High:7.09
Open:6.98
Low:6.88
Close:6.83
52wk High:9.75
52wk Low:2.76
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.72
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:9.58
PE(LYR):-11.55

Loading ...

OverviewCompanyNewsFilings

Nuvation Bio Publishes Corporate Presentation on IBTROZI ROS1 Lung Cancer and Safusidenib IDH1 Glioma Pipeline

Reuters
·
Mar 03

Nuvation Bio posts Q4 collaboration and license agreements revenue of USD 26.2 million, up 4.6x

Reuters
·
Mar 03

Nuvation Bio Q4 EPS $(0.11) Misses $(0.09) Estimate, Sales $41.865M Beat $37.326M Estimate

Benzinga Earnings
·
Mar 03

BRIEF-Nuvation Bio Q4 EPS USD -0.11

Reuters
·
Mar 03

Nuvation Bio Q4 Pretax Profit USD -36.592 Million

THOMSON REUTERS
·
Mar 03

Press Release: Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 03

Nuvation Bio (NUVB) Is Up 8.6% After Advancing Safusidenib Into Phase 3 Brain Cancer Trial

Simply Wall St.
·
Feb 28

Nuvation Bio Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Feb 27

Nuvation Bio to Join TD Cowen Annual Health Care Conference Fireside Chat

Reuters
·
Feb 26

Analyst Rate

Buy
Buy
91.67%
Hold
8.33%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 04, 2026 Post-Mkt
Financial Report Announcement
Mar 02, 2026 Post-Mkt
Financial Report Announcement
Jan 12, 2026 Pre-MKt
Financial Report Announcement
Nov 03, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-15.80
Current
-8.10
Sector Average
9.86%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-15.80
Maximum
-0.99
+1 STD
-0.47
Minimum
-34.17
-1 STD
-15.72
Average
-8.10

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.